Oral Recombinant Methioninase Prevents Nonalcoholic Fatty Liver Disease in Mice on a High Fat Diet

Background/Aim: We have recently shown that oral recombinant methionase (o-rMETase) prevents obesity and diabetes onset in mice on a high-fat (HF) diet. The present study aimed to determine if o-rMETase can inhibit the onset of nonalcoholic fatty liver disease (NAFLD) onset in mice on a high-fat die...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:In Vivo
Autori principali: TASHIRO, YOSHIHIKO, HAN, QINGHONG, TAN, YUYING, SUGISAWA, NORIHIKO, YAMAMOTO, JUN, NISHINO, HIROTO, INUBUSHI, SACHIKO, SUN, YU, LIM, HYEIN, AOKI, TAKESHI, MURAKAMI, MASAHIKO, TAKAHASHI, YOSHIHISA, BOUVET, MICHAEL, HOFFMAN, ROBERT M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: International Institute of Anticancer Research 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7279815/
https://ncbi.nlm.nih.gov/pubmed/32354883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11866
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi